跳至主要内容
临床试验/CTRI/2018/07/014965
CTRI/2018/07/014965已完成未知

A prospective, randomized control study to compare the effectiveness and safety of minocycline and clofazimine in patients of chronic and recurrent erythema nodosum leprosum

one0 个研究点目标入组 57 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
one
入组人数
57

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Chronic and recurrent ENL cases of leprosy regardless of age, sex and treatment status with MDT
  • 2.Patients not on treatment with paracetamol, pentoxifylline, colchicine, methotrexate, azathioprine, TNF inhibitors etc.,
  • 3.Patients who can give valid consent.
  • 4.Willing for monthly follow-up visits for at least 6 months

排除标准

  • 1.Pregnant and lactating mothers
  • 2.Patients allergic to tetracyclines, clofazimine
  • 3.Patients with HIV, Hepatitis B and Hepatitis C
  • 4.Inability to come for monthly follow up visits for 6 months
  • 5.Those who cannot provide consent for the study
  • 6.Patients with cardiac, hepatic, renal disease, neurological diseases, bleeding disorder, mental diseases, cerebrovascular diseases and showing abnormal baseline laboratory parameters

研究者

发起方
one

相似试验